ORGS

Orgenesis (ORGS)

Orgenesis Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ORGS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/31	19 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2024/05/24	22 : 16	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:ORGS	Orgenesis Inc
2024/05/23	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2024/05/21	20 : 00	GlobeNewswire Inc.	Orgenesis Provides Business Update for the First Quarter of 2024	NASDAQ:ORGS	Orgenesis Inc
2024/05/21	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ORGS	Orgenesis Inc
2024/05/16	05 : 01	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:ORGS	Orgenesis Inc
2024/05/07	04 : 30	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ORGS	Orgenesis Inc
2024/05/07	04 : 28	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ORGS	Orgenesis Inc
2024/05/07	04 : 26	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ORGS	Orgenesis Inc
2024/04/16	06 : 07	GlobeNewswire Inc.	Orgenesis Provides Year End Business Update	NASDAQ:ORGS	Orgenesis Inc
2024/04/11	01 : 00	GlobeNewswire Inc.	Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility	NASDAQ:ORGS	Orgenesis Inc
2024/03/18	21 : 30	GlobeNewswire Inc.	Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference	NASDAQ:ORGS	Orgenesis Inc
2024/03/13	21 : 30	GlobeNewswire Inc.	Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes	NASDAQ:ORGS	Orgenesis Inc
2024/03/04	22 : 30	GlobeNewswire Inc.	Orgenesis Inc. Announces $2.3 Million Private Placement	NASDAQ:ORGS	Orgenesis Inc
2024/02/29	22 : 30	GlobeNewswire Inc.	Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing	NASDAQ:ORGS	Orgenesis Inc
2024/01/31	23 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2024/01/31	23 : 15	GlobeNewswire Inc.	Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic	NASDAQ:ORGS	Orgenesis Inc
2024/01/25	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2024/01/23	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2024/01/09	07 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ORGS	Orgenesis Inc
2024/01/09	07 : 36	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ORGS	Orgenesis Inc
2024/01/05	20 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2023/11/14	22 : 30	GlobeNewswire Inc.	Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM	NASDAQ:ORGS	Orgenesis Inc
2023/11/14	06 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ORGS	Orgenesis Inc
2023/11/14	06 : 15	GlobeNewswire Inc.	Orgenesis Provides Business Update for the Third Quarter of 2023	NASDAQ:ORGS	Orgenesis Inc
2023/11/09	21 : 41	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ORGS	Orgenesis Inc
2023/11/08	23 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORGS	Orgenesis Inc
2023/11/08	23 : 00	GlobeNewswire Inc.	Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering	NASDAQ:ORGS	Orgenesis Inc
2023/11/02	21 : 00	GlobeNewswire Inc.	Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding	NASDAQ:ORGS	Orgenesis Inc
2023/10/31	10 : 30	GlobeNewswire Inc.	Orgenesis Announces Withdrawal of Proposed Public Offering	NASDAQ:ORGS	Orgenesis Inc